Concord Drugs

35.50
-2.22
(-5.89%)
Market Cap
35.48
EPS
0.01
PE Ratio (TTM)
74.26
Dividend Yield
0.00
Industry
Healthcare
52 Week High
48.95
52 Week low
30.59
PB Ratio
1.11
Debt to Equity
0.53
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-13.82 %
Net Income Growth
-50.00 %
Cash Flow Change
-52.41 %
ROE
-54.98 %
ROCE
-17.47 %
EBITDA Margin (Avg.)
2.62 %

Yearly Financial Results

Annual Financials
2022
2023
2024
TTM
Revenue
59
52
45
51
Expenses
53
48
41
47
EBITDA
6
5
4
4
Operating Profit %
9 %
9 %
9 %
7 %
Depreciation
2
2
2
1
Interest
2
2
2
2
Profit Before Tax
2
1
1
0
Tax
1
0
0
0
Net Profit
2
1
1
-0
EPS in ₹
1.82
1.06
0.47
-0.00

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
56
58
59
Fixed Assets
14
13
12
Current Assets
42
44
45
Capital Work in Progress
1
1
2
Investments
0
1
1
Other Assets
42
44
45
Total Liabilities
56
58
59
Current Liabilities
24
22
21
Non Current Liabilities
4
5
4
Total Equity
28
32
34
Reserve & Surplus
20
22
24
Share Capital
9
9
10

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
0
0
Investing Activities
-2
-2
-1
Operating Activities
1
2
1
Financing Activities
2
1
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
44.38 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
52.13 %
52.13 %
52.13 %
55.41 %
55.41 %
55.41 %
55.41 %
54.39 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
54.90 %
50.05 %
50.05 %
50.47 %
50.65 %
50.68 %
50.67 %
50.71 %
47.60 %
47.59 %
47.54 %
44.29 %
44.27 %
44.28 %
44.30 %
45.11 %
No of Share Holders
2,173
2,826
2,826
3,071
3,047
3,036
3,188
3,321
3,215
3,198
3,957
3,963
4,032
4,734
4,755
5,073

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,756.85 4,21,527.16 37.86 49,887.20 12.06 9,648 27.34 36.22
5,876.85 1,56,011.90 86.72 8,184.00 0.89 1,600 46.55 47.97
1,447.20 1,16,877.90 25.33 26,520.70 14.17 4,155 12.95 38.47
1,337.20 1,11,577.42 20.90 28,905.40 12.36 5,578 -9.47 52.63
3,215.05 1,08,811.90 63.29 10,785.70 11.59 1,656 17.36 36.47
2,596.00 1,07,102.37 52.12 10,615.60 19.57 1,942 28.89 38.60
984.90 99,103.99 23.54 19,831.50 13.82 3,831 14.57 50.66
2,128.70 97,110.78 37.44 20,141.50 19.94 1,936 73.53 39.84
1,147.55 66,649.89 18.88 29,559.20 17.55 3,169 8.66 30.14
5,201.50 62,191.73 28.99 12,978.40 9.84 1,812 14.16 33.33

Corporate Action

Technical Indicators

RSI(14)
Neutral
39.92
ATR(14)
Volatile
2.35
STOCH(9,6)
Neutral
33.21
STOCH RSI(14)
Neutral
22.33
MACD(12,26)
Bearish
-0.18
ADX(14)
Weak Trend
19.89
UO(9)
Bearish
44.85
ROC(12)
Downtrend And Accelerating
-2.15
WillR(14)
Oversold
-81.48